Skip to content

Home About Services Contact

Search…

The Daily Intake

Legal and Regulatory updates for the food and supplement industry

FDA

Subscribe to FDA

CSPI Urges FDA to Take Further Action on Tianeptine Products

Posted on August 28, 2020

On August 25, 2020, the Center for Science in the Public Interest (CSPI) sent a letter urging FDA to take further enforcement against manufacturers, distributors, and retailers that sell products

…
Continue Reading CSPI Urges FDA to Take Further Action on Tianeptine Products

Independent Testing of Well-Known Beverages Provides Further Evidence of CBD Products Not Meeting Label Claims for Cannabidiol Content

Posted on August 24, 2020

We have discussed the slow progress toward a regulatory pathway for lawfully marketing FDA-regulated food and dietary supplement products that contain cannabidiol (CBD). While CBD products remain technically illegal (aside

…
Continue Reading Independent Testing of Well-Known Beverages Provides Further Evidence of CBD Products Not Meeting Label Claims for Cannabidiol Content

FDA and OSHA Publish Employee Health and Food Safety Checklist for Human and Animal Food Operations During COVID-19

Posted on August 21, 2020

To help the food industry protect employees and maintain the safety of human and animal food throughout adjustments to operations during the COVID-19 public health emergency, the U.S. Food and

…
Continue Reading FDA and OSHA Publish Employee Health and Food Safety Checklist for Human and Animal Food Operations During COVID-19

FDA Issues Final Rule on Gluten-Free Labeling of Fermented and Hydrolyzed Foods

Posted on August 13, 2020

On August 12, 2020, the U.S. Food and Drug Administration (“FDA” or “Agency”) issued a final rule to establish compliance requirements for fermented and hydrolyzed foods, or foods that contain

…
Continue Reading FDA Issues Final Rule on Gluten-Free Labeling of Fermented and Hydrolyzed Foods

FDA Issues Guidance on Action Level for Inorganic Arsenic in Infant Rice Cereals

Posted on August 7, 2020

The U.S. Food and Drug Administration (FDA) issued its final guidance document, “Inorganic Arsenic in Rice Cereals for Infants: Action Level Guidance for Industry,” which finalizes the approach

…
Continue Reading FDA Issues Guidance on Action Level for Inorganic Arsenic in Infant Rice Cereals

FDA Releases a New EPA-Approved Protocol for Evaluating the Efficacy of Antimicrobial Pesticides in Agricultural Water

Posted on August 3, 2020

In the United States between 2009 and 2018, the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) identified 40 outbreaks of food-borne illness

…
Continue Reading FDA Releases a New EPA-Approved Protocol for Evaluating the Efficacy of Antimicrobial Pesticides in Agricultural Water

FDA Sends Warning Letters to Companies Illegally Selling Hangover Supplements

Posted on July 30, 2020

In a July 29, 2020 news release, the U.S. Food and Drug Administration (FDA) announced that it had issued warning letters to seven companies for illegally selling unapproved products

…
Continue Reading FDA Sends Warning Letters to Companies Illegally Selling Hangover Supplements

US House Appropriates $3.2 Billion for FDA for Fiscal Year 2021

Posted on July 29, 2020

On July 24, 2020, the US House of Representatives passed a four-bill minibus that set FDA’s fiscal year 2021 budget at $3.212 billion – a $40.8 million increase over last

…
Continue Reading US House Appropriates $3.2 Billion for FDA for Fiscal Year 2021

FDA Issues Final Compliance Policy Guide on the Use of The Seafood List to Determine Acceptable Seafood Names

Posted on July 24, 2020

The U.S. Food and Drug Administration (FDA) has issued a final Compliance Policy Guide (CPG), Sec. 540.750, on the “Use of The Seafood List to Determine Acceptable Seafood Names

…
Continue Reading FDA Issues Final Compliance Policy Guide on the Use of The Seafood List to Determine Acceptable Seafood Names

FDA Announces Qualified Health Claim for Certain Cranberry Products and Urinary Tract Infections

Posted on July 23, 2020

On July 21, 2020, the U.S. Food and Drug Administration (FDA) announced in a letter of enforcement discretion that it does not intend to object to the use of certain

…
Continue Reading FDA Announces Qualified Health Claim for Certain Cranberry Products and Urinary Tract Infections

Post navigation

Search…

Stay Connected

RSS LinkedIn Twitter

Subscribe By Email Your website url

Blog Authors Show/Hide

Nury Yoo
Lisa Alsobrook
Owen Chaput
Melvin S. Drozen
Jill Mahoney
Evangelia Pelonis
Nicholas Prust
Natalie Rainer
Arturo Reyes
Frederick A. Stearns
Ann Wilkes

Archives

Archives

Recent Updates

Blue Bell Fined Record $17.25 Million in Post-Conviction Criminal Penalties for Listeria Outbreak
Plant-Based Food Producers Sue State of Oklahoma in Federal Court to Block Disclaimer Requirement (Law360 Subscription Required)
Conagra Challenges Legal Sufficiency of Presuit Demand Letter in “100% Natural” Class Action Lawsuit (Law360 Subscription Required)
FSIS Proposes to Expand Eligibility for Generic Label Approval and to Discontinue FSIS Evaluation of Voluntarily Submitted Labels That are Eligible for Generic Approval
Consumer Reports Evaluates Pesticide Residue on Fruits and Vegetables

The Daily Intake

Keller and Heckman LLP

Brussels|Paris|San Francisco|Shanghai|Washington, DC

To join our mailing list, click here.

RSS LinkedIn Twitter

DisclaimerPrivacy Policy

About our Firm

Keller and Heckman, founded in 1962, has a broad practice in the areas of regulatory law, litigation, and business transactions, serving both domestic and international clients. Our firm is a pioneer in the use of interdisciplinary approaches to problem-solving. Since 1971, we have had an in-house scientific staff that works closely with the firm’s attorneys on matters of technical complexity. Many of our attorneys also have government experience and expertise in multiple areas of the law.

Copyright © 2020, Keller and Heckman LLP. All Rights Reserved.

Powered By LexBlog